NCT06721598 2024-12-06An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative DisordersNational Research Center for Hematology, RussiaNot yet recruiting60 enrolled